Europe Hemodynamic Monitoring System Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Non-Invasive Hemodynamic Monitoring Systems, Minimally Invasive Hemodynamic Monitoring Systems, and Invasive Hemodynamic Monitoring Systems), P

Europe Hemodynamic Monitoring System Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Non-Invasive Hemodynamic Monitoring Systems, Minimally Invasive Hemodynamic Monitoring Systems, and Invasive Hemodynamic Monitoring Systems), Product (Monitors and Disposables), and End User (Hospitals, Home Care, Cath Labs, and Ambulatory Care Center)

The Europe hemodynamic monitoring system market is expected to grow from US$ 434.63 million in 2022 to US$ 616.34 million by 2028. It is estimated to grow at a CAGR of 6.0% from 2022 to 2028.

Growing Geriatric Population Drives Hemodynamic Monitoring System Market in Europe

Higher cases of CVDs occur among geriatric people. According to the Eurostat, over one fifth, i.e.,20.8 % of the European Union population was aged 65 or more in 2021. As per the report ‘The UK’s ageing population’ by the House of Commons (UK Parliament), the UK's population is witnessing a massive age shift. In 2019, there were more than 12.3 million people aged 65 or more in the region and the figure is projected to reach 17.4 million, i.e., around 24% of the entire population by 2043. The rising geriatric population is expected to lead to various chronic health conditions, such as high blood pressure, obesity, and diabetes, the primary causes of cardiovascular diseases. The monitoring services for the geriatric population are widely provided in home care settings. Therefore, the demand for hemodynamic monitoring systems in these settings is growing, thereby fostering the growth of Europe hemodynamic monitoring system market.

Europe Hemodynamic Monitoring System Market Overview

The Europe hemodynamic monitoring system market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. The region holds a significant market share in the hemodynamic monitoring system market. Europe occupies a significant position in the hemodynamic monitoring system market and is estimated to register a robust growth rate over the forecast period. The Europe hemodynamic monitoring system market is expected to witness significant growth during the forecast period due to factors such as the significant growth in elderly population, growing cardiovascular diseases along with increasing diabetes and hypertension in the region.

Europe Hemodynamic Monitoring System Market Revenue and Forecast to 2028 (US$ Million)

Europe Hemodynamic Monitoring System Market Segmentation

The Europe hemodynamic monitoring system market is segmented into type, product, end user, and country.

Based on type, the Europe hemodynamic monitoring system market is segmented into non-invasive hemodynamic monitoring systems, minimally invasive hemodynamic monitoring systems, and invasive hemodynamic monitoring systems. The invasive hemodynamic monitoring systems segment held the largest Europe hemodynamic monitoring system market share in 2022.

Based on product, the Europe hemodynamic monitoring system market is segmented into monitors and disposables. The disposables segment held the larger Europe hemodynamic monitoring system market share in 2022.

Based on end user, the Europe hemodynamic monitoring system market is segmented into hospitals, home care, cath labs, and ambulatory care center. The hospitals segment held the largest Europe hemodynamic monitoring system market share in 2022

Based on country, the Europe hemodynamic monitoring system market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe hemodynamic monitoring system market share in 2022.

Baxter International Inc, Change Healthcare, DELTEX MEDICAL, Edwards Lifesciences Corporation, General Electric Co, Getinge Group, ICU MEDICAL INC., International Business Machines Corp, Koninklijke Philips NV; Masimo; Osypka Medical GmbH; Schwarzer Cardiotek; and Siemens Healthineers AG are the leading companies operating in the Europe hemodynamic monitoring system market.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe hemodynamic monitoring system market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in Europe hemodynamic monitoring system market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution